首页 > 研究报告 > 其他报告 >  > 招银国际-开拓药业-B-09939.HK-Continue to pursue the development of p

招银国际-开拓药业-B-09939.HK-Continue to pursue the development of proxalutamide for treatment of COVID-19-2

上传日期:2022-02-12 16:28:48 / 研报作者:Jill WuAndy Wang / 分享用户:1005795